Skip to content

Learn more about an Investigational Oral Medication for MS

Exploring The Possibility Through Clinical Studies

Clinical Studies for RRMS

Have you been diagnosed with Relapsing-Remitting Multiple Sclerosis (RRMS)? If so, you may qualify for a clinical study to evaluate the safety and effectiveness of an investigational oral medication.

Qualified participants will receive study-related medical exams, laboratory tests and study medication at no cost. Study coordinators are seeking participants who are 18 to 55 years of age with a clinical diagnosis of RRMS and at least one relapse during the past 12 months.

Pre-Screen Yourself to participate in our clinical studies
Learn About the Medication for clinical studies
RRMS Facts
biogen idec

Biogen Idec may modify this website and the rules and regulations governing its use, at any time. Modifications will be posted on the website, so please check back when you use the website. By continuing use of the website after such changes are posted you will be accepting such changes.

For more information, contact BG12studies@biogenidec.com.